14 citations · 33 across the 7 of their papers we have counts for
5 papers · 1 filter
Sample size calculation based on the difference in restricted mean time lost for clinical trials with competing risks
Xiang Geng, Zhaojin Li, Chengfeng Zhang +5
Computation of sample size is important when designing clinical trials. The presence of competing risks makes the design of clinical trials with time-to-event endpoints cumbersome.…
Time-varying effect in the competing risks based on restricted mean time lost
Zhiyin Yu, Zhaojin Li, Chengfeng Zhang +3
Patients with breast cancer tend to die from other diseases, so for studies that focus on breast cancer, a competing risks model is more appropriate. Considering subdistribution ha…
Analysis of dynamic restricted mean survival time based on pseudo-observations
Zijing Yang, Chengfeng Zhang, Yawen Hou +1
In clinical follow-up studies with a time-to-event end point, the difference in the restricted mean survival time (RMST) is a suitable substitute for the hazard ratio (HR). However…
Restricted mean survival time regression model with time-dependent covariates
Chengfeng Zhang, Hongji Wu, Baoyi Huang +3
In clinical or epidemiological follow-up studies, methods based on time scale indicators such as the restricted mean survival time (RMST) have been developed to some extent. Compar…
The use of restricted mean time lost under competing risks data
Jingjing Lyu, Yawen Hou, Zheng Chen
Background: Under competing risks, the commonly used sub-distribution hazard ratio (SHR) is not easy to interpret clinically and is valid only under the proportional sub-distributi…